| General Information |
| Business: |
(Incorporated in the Cayman Islands)
We are a newly organized healthcare SPAC with a focus on biotech and the broader life sciences.
Someit Sidhu, our CEO and chairman, is the founder of numerous healthcare companies. He is the CEO as well as the founder of Khanda Therapeutics.
(Note: JATT III Acquistion (JTTT) priced its SPAC IPO in sync with the terms in the prospectus – 6 million shares at $10.00 each – to raise $60 million on Tuesday night, Aug. 25, 2026. Background: JATT III Acquisition (JTTT Proposed) filed its S-1 on Aug. 10, 2026, and disclosed the terms of its SPAC IPO – 6 million shares at $10.00 each – to raise $60 million. The company is not offering units with warrants or rights included.)
|
| Industry: |
BLANK CHECKS |
| Employees: |
0 |
| Founded: |
2026 |
| Contact Information |
| Address |
153 Central Avenue C/O 56 Westfield, NJ 07091 |
| Phone Number |
201-688-0364 |
| Web Address |
|
| View Prospectus: |
JATT III Acquisition (Stock-Only) |
| Financial Information |
| Market Cap |
$77.25mil |
| Revenues |
$0.0 mil (last 12 months) |
| Net Income |
$0.0 mil (last 12 months) |
| IPO Profile |
| Symbol |
JTTT |
| Exchange |
NASDAQ |
| Shares (millions): |
6.0 |
| Price range |
$10.00 - $10.00 |
| Est. $ Volume |
$60.0 mil |
| Manager / Joint Managers |
Guggenheim Securities |
| CO-Managers |
|
| Expected To Trade: |
8/26/2026 |
|
Status:
|
Priced |
| Quiet Period Expiration Date: |
Available only to Subscribers |
| Lock-Up Period Expiration Date: |
Available only to Subscribers |
| SCOOP Rating |
Available only to Subscribers |
| Rating Change |
Available only to Subscribers |
